Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

JAK inhibitors may help improve symptoms in adults with APECED.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Intralesional cidofovir might be a good alternative treatment.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Clascoterone cream 1% is effective and well-tolerated for treating acne and other related conditions.

The treatment cleared psoriasis in some patients but caused side effects in most.

Bortezomib chemotherapy can cause temporary skin rashes.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.